Uterine Serous Papillary Carcinoma: A Retrospective Analysis of 22 Cases

OBJECTIVE: The cases of 22 patients with uterine serous papillary carcinoma (USPC) were reviewed for this study. STUDY DESIGN: The data of 22 patients diagnosed with USPC was examined. 18 patients underwent formal staging surgery including type I hysterectomy, bilateral salphingo-oophorectomy, para-aortic and bilateral pelvic lymphadenectomy, appendectomy and omentectomy in our clinic. Four patients were sent to our clinic from other hospitals after primary surgery. Staging of the disease was based on the FIGO 1998. RESULTS: At the time of diagnosis the median age was 62.2 years. The most common clinic complaint was vaginal bleeding (86.3%). seven patients were stage I (31.8%), one was stage II (4.5%), eight were stage III (36.3%) and six were stage IV (27.3%). Median disease-free survival was 25 months. Recurrence was not influenced by the stage of disease, lymphatic metastasis, depth of myometrial invasion, adjuvant therapy and the type of adjuvant treatment. However, the recurrence was influenced by positive cytology and invasion of omentum. CONCLUSIONS: Staging surgery should be performed on patients with USPC. Invasion of omentum and positive cytology were poor prognostic factors. The effect of adjuvant therapy on prognosis is not clear.

[1]  A. Mariani,et al.  Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. , 2007, Gynecologic oncology.

[2]  A. Mariani,et al.  Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. , 2007, Gynecologic oncology.

[3]  Sun Li-ping Uterine papillary serous carcinoma:a clinicopathological study of 24 cases , 2006 .

[4]  T. Herzog,et al.  Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy. , 2003, Gynecologic oncology.

[5]  J. Taxy,et al.  Neoadjuvant chemotherapy in uterine papillary serous carcinoma. , 1996, Gynecologic oncology.

[6]  N. Hacker,et al.  Uterine papillary serous carcinoma. A clinical study , 1995, Cancer.

[7]  J. Cain,et al.  Uterine papillary serous carcinoma: patterns of metastatic spread. , 1994, Gynecologic oncology.

[8]  T. Högberg,et al.  Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. , 1993, Gynecologic oncology.

[9]  J. Vardi,et al.  The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging , 1992, Obstetrics and gynecology.

[10]  V. Abeler,et al.  Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases. , 1991, Gynecologic oncology.

[11]  R. Kryscio,et al.  Stage i serous papillary carcinoma of the endometrium , 1989, Cancer.

[12]  P. Rosenberg,et al.  The Prognosis In Early Endometrial Carcinoma , 1989 .

[13]  H. Michael,et al.  Malignant papillary lesions of the endometrium. , 1987, Gynecologic oncology.

[14]  M. Hendrickson,et al.  Therapeutic approaches to uterine papillary serous carcinoma: a preliminary report. , 1987, Gynecologic oncology.

[15]  R. Kempson,et al.  Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma , 1982, The American journal of surgical pathology.

[16]  S. Mills,et al.  Serous papillary carcinoma of the endometrium. A clinicopathologic study of 11 cases. , 1982, Diagnostic gynecology and obstetrics.

[17]  S. Carinelli,et al.  Endometrial Adenocarcinoma with Psammoma Bodies , 1979, Tumori.